NOTE 8 - EQUITY

Preferred Stock

The Company has 20,000,000 shares of $0.0001 par value preferred stock authorized and has designated a Series A, a Series B and a series C preferred stock and a series D preferred stock. The Company has authorized 5, 000,000 series A and B shares each plus 1,500,000 each of series C and D preferred shares Each share of the Series A preferred stock is convertible into ten common shares and carries voting rights on the basis of 100 votes per share.  Each share of the Series B preferred stock is convertible into ten common shares and carries no voting rights. Each of the Series C preferred shares are non-voting and are convertible to common stock as a “Blank Check” designation with terms and conditions as set by the board of directors. Each of the series D preferred shares are non-voting and may be converted into common shares as a Blank Check” designation with the terms and conditions as set forth by the board of directors.

On May 9, 2019, DTII’s Board of Directors unanimously resolved to revise the terms of the company’s Series A and Series B Preferred Shares. Under the new terms, the conversion right of both Series A and B Preferred Shares was changed from five (5) shares of DTII common stock for each one (1) share of Preferred Stock, to a new conversion right of ten (10) shares of DTII common stock for each one (1) share of Preferred Stock. The revised conversion terms apply to all issued and outstanding Preferred Shares and to future issuances of Series A and Series B Preferred Stock. The Board received the unanimous consent to the changed terms from each current Preferred shareholder.

During the year ended April 30, 2024, the Company issued 85,000 series B preferred shares to a related party with a value of $15,139.

During the year ended April 30, 2025 the  Company issued 10,686,860 shares of common  stock for the conversion of 1,068,686 of Series B preferred shares.

During the year ended April 30, 2025 the  Company issued 213,314 shares of series B preferred shares  to settle $843,831 for accrued payables. The result of this issuance was a gain on debt of approximately $773,231.

During the year ended April 30, 2025 the Company issued 1,631,143 shares of common stock  for the conversion of 26 shares of series D preferred shares.

During the year ended April 30, 2025 the Company issued 10,000,000 shares with an aggregate value of $695,000 for the payment of related party debt. As part of the conversion the Company recognized a loss on notes of $295,000.

During the year ended April 30, 2025 the Company issued 94,991 shares of series B preferred with a value of $367,431 to 2 related parties for accrued liabilities.

As of April 30, 2025 the Company has 3,635,949 shares of preferred stock consisting of 2,535,135 Series A shares, 1,100,254 Series B shares and 560 Series D preferred shares issued and outstanding. The conversion price for the 560 series D shares issued is $0.50 or 80% of the lowest trading price 20 days prior to conversion.

Common Stock:

The Company has 600,000,000 shares of $0.0001 par value common stock authorized.  During the year ended April 30, 2022 the Company completed a reverse split of one share for each 500 shares. The presentation of the common shares are retroactive in the number of shares outstanding for both 2022 and 2021. The reverse resulted in a decrease in common stock and an increase in paid in capital.

During the year ended April 30, 2024, the Company issued 200,000 shares of common stock with a value of $10,000 for cash.

During the year ended April 30, 2024 the Company issued 1,262,617 shares of common stock with a value of $25,996 for the conversion of  convertible debt.

During the year ended April 30, 2024 the Company issued 1,380,191  shares of common stock for the conversion of series B preferred shares.

During the year ended April 30, 2024 the Company issued 685,825 shares of common stock with a value of $34,291 for convertible debt.

During the year ended April 30, 2024 the Company issued 200,000 shares of common stock with a value of $6,000 for service.

During the year ended April 30, 2024 the Company issued 3,902,340 shares of common stock for the conversion of series A preferred shares.

During the year ended April 30, 2024, the Company issued 295,863 shares of common stock for the conversion of series D preferred shares.

During the year ended April 30, 2025 the  Company issued 10,686,860 shares of common  stock for the conversion of 1,068,686 of Series B preferred shares.

During the year ended April 30, 2025 the Company issued 850,000 shares of common stock with a value of $55,000 for the payment of consulting fees.

During the year ended April 30, 2025 the Company issued 1,631,143 shares of common stock  for the conversion of 26 shares of series D preferred shares.

During the year ended April 30, 2025 the Company issued 1,250,000 shares of common stock with a value of $62,500 for the conversion of convertible debt.

During the year ended April 30, 2025 the Company issued 10,000,000 shares with an aggregate value of $695,000 for the payment of related party debt. As part of the conversion the Company recognized a loss on notes of $295,000.